Integra LifeSciences (NASDAQ:IART) Updates Q3 2023 Earnings Guidance
Integra LifeSciences (NASDAQ:IART – Get Free Report) issued an update on its third quarter 2023 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $0.76-$0.80 for the period, compared to the consensus estimate of $0.97. The company issued revenue guidance of $386.00 million-$390.00 million, compared to the consensus revenue estimate […]